Evaluating gastrointestinal eosinophilic disorders in children
Official title: National, Multicenter, Retrospective, Prospective Study to Evaluate Pediatric Gastrointestinal Eosinophilic Disorders
Run by Fondazione IRCCS Policlinico San Matteo di Pavia · NCT05219903 · Data updated 2026-11-12
This study looks at how common eosinophilic gastrointestinal disorders are in children to help improve understanding and treatment of these conditions.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 0 Years to 18 Years |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | Fondazione IRCCS Policlinico San Matteo di Pavia Academic / other |
| Locations | 1 site (Pavia) |
| Status | Recruiting |
| Started | January 20, 2022 |
| Main results expected | January 31, 2027 |
| Study ends | January 31, 2027 |
| Registry record updated | July 25, 2024 |
| Trial ID | NCT05219903 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are children aged 0-18 years diagnosed with eosinophilic gastrointestinal disorders.
✕Probably not a fit
Patients diagnosed with eosinophilic gastrointestinal disorders more than five years prior or with secondary causes of intestinal eosinophilic inflammation will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to evaluate the prevalence and incidence of eosinophilic gastrointestinal disorders (EGIDs) in pediatric patients across multiple centers in Italy. It focuses on conditions such as eosinophilic esophagitis, gastritis, gastroenteritis, and colitis, which are increasingly recognized but poorly understood. By collecting data from patients aged 0-18 years, the study seeks to provide clearer epidemiological insights into these disorders and improve diagnostic and therapeutic guidelines. Informed consent will be obtained from patients and their guardians for participation.
Why it matters
Potential benefit: If successful, this study could lead to better understanding and management of eosinophilic gastrointestinal disorders in children.
How similar studies have gone: While there have been some retrospective studies on eosinophilic gastrointestinal disorders, this study aims to fill significant gaps in the understanding of non-esophageal forms, making it a novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: \- All EGIDs patients aged 0-18 years and followed at the centers involved in the study will be considered eligible. Informed consent must be obtained from each enrolled patient and signed by a parent/legal guardian and patient (when older than six years). Exclusion Criteria: \- This study will not include patients with: 1. a diagnosis of EGIDs made more than five years before the study participation; 2. a diagnosis of EoE not in line with current international guidelines; 3. a secondary cause of intestinal eosinophilic inflammation (inflammatory bowel diseases, autoimmune diseases, vasculitis, graft versus host disease, malignancies).
Where it's running
-
IRCCS Policlinico San Matteo
Pavia, Italy Recruiting
Study contacts
- Study coordinator: Amelia Licari, MD
- Email: a.licari@smatteo.pv.it
- Phone: +390382502629
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Registry for Eosinophilic Gastrointestinal Disorders
This study is collecting information from people with Eosinophilic Gastrointestinal Disorders to better understand their symptoms and improve treatments for them.
-
Evaluating outcomes in eosinophilic gastrointestinal disorders
This study is trying to find the best ways to measure how well people with eosinophilic gastrointestinal disorders are doing by looking at their symptoms and tissue samples over time.
-
Upadacitinib for Eosinophilic Esophagitis in adults not responding to standard therapy
This study tests whether upadacitinib, taken with topical corticosteroids, can reduce disease activity in adults with eosinophilic esophagitis who still have symptoms.
-
A registry for adults with esophageal movement and reflux problems.
This project will collect esophageal function tests (manometry, pH-impedance, FLIP) and clinical data from adults with reflux or swallowing symptoms to see if combining these results helps guide diagnosis and long-term care.
-
Using a mucosal impedance device to help diagnose chronic esophageal problems
This test tries a mucosal impedance device during upper endoscopy to see if it helps diagnose people with chronic reflux (GERD) or eosinophilic esophagitis.
-
Esophageal string test to screen for eosinophilic esophagitis in adults of African descent with swallowing problems
This study will test whether a 1-hour esophageal string test can detect eosinophilic esophagitis in adults born in Africa (or with African parents) who have trouble swallowing.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.